Inventor
ARISTA LUCA
CH14 patents
⚠️ This page may combine multiple inventors who share the name “ARISTA LUCA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS10947218B2Mar 16, 2021
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG6 citations81
US10710980B2Jul 14, 2020
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG8 citations81
US11541056B2Jan 3, 2023
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives
NOVARTIS AG2 citations71
US12466808B2Nov 11, 2025
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG0 citations60
US12441733B2Oct 14, 2025
Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors
NOVARTIS AG0 citations59
US11613543B2Mar 28, 2023
Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors
NOVARTIS AG1 citations59
US11160797B2Nov 2, 2021
Pyridinone derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG0 citations46
GLAXO GROUP LTD
4 patentsUS7855298B2Dec 21, 2010
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD11 citations82
US7745458B2Jun 29, 2010
Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD2 citations60
US7790758B2Sep 7, 2010
Compounds which potentiate glutamate receptor and uses thereof in medicine
GLAXO GROUP LTD2 citations58
US7807698B2Oct 5, 2010
Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor
GLAXO GROUP LTD1 citations51